v3.26.3
Equity Compensation and Other Benefit Plans (Tables)
 9 Months Ended
Sep. 30, 2026
Compensation Related Costs [Abstract]  
Schedule of Expenses Related to Equity-Based Compensation
The following table presents the Company’s expenses related to its equity-based compensation instruments for the three and nine months ended September 30, 2026 and 2025:
Three Months Ended
September 30,		Nine Months Ended
September 30,
(In Thousands)2026202520262025
RSUs$2,105 $1,861 $10,648 $10,187 
Total$2,105 $1,861 $10,648 $10,187 
Schedule of Expenses (Reversal) Related to Deferred Compensation Plans The following table presents the Company’s expenses (reversal) related to its Deferred Plans for the three and nine months ended September 30, 2026 and 2025:
 
Three Months Ended
September 30,		Nine Months Ended
September 30,
(In Thousands)2026202520262025
Non-employee directors$(484)$23 $(169)$24 
Total$(484)$23 $(169)$24 
Schedule of Aggregate Income Deferred by Participants and Associated Liability Under Deferred Compensation Plans
The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through September 30, 2026 and December 31, 2025 that had not been distributed and the Company’s associated liability for such deferrals at September 30, 2026 and December 31, 2025:
 
September 30, 2026December 31, 2025
(In Thousands)
Undistributed Income Deferred (1)
 Liability Under Deferred Plans
Undistributed Income Deferred (1)
 Liability Under Deferred Plans
Non-employee directors$2,752 $2,573 $2,742 $2,738 
Total$2,752 $2,573 $2,742 $2,738 
(1) Represents the cumulative amounts that were deferred by participants through September 30, 2026 and December 31, 2025, which had not been distributed through such respective date.